Italy has announced that it has successfully developed a vaccine to contain coronavirus. Italy has claimed that the vaccine works on humans, Arab News reported.
As per the tests carried out at Rome's infectious-disease Spallanzani Hospital, the coronavirus vaccine has antibodies generated in mice that work on human cells, CNBC TV 18 reported.
“This is the most advanced stage of testing of a candidate vaccine created in Italy,” Luigi Aurisicchio, CEO of Takis, the firm developing the medication told Italian news agency ANSA in a report.
“Human tests are expected after this summer,” Aurisicchio was quoted as saying.
Scientists experimented with the vaccine on mice that had successfully developed antibodies that blocked the virus from infecting the cells.
Researchers further observed that the five vaccine candidates generated a large number of antibodies, and selected two with the best results, the report said.
All of the vaccine candidates currently being developed are based on the genetic material of DNA protein "spike".
“So far, the immunity generated by most of our five vaccine candidates has an effect on the virus. We expect better results after the second vaccination,” Dr Emanuele Marra from Takis was quoted in the CNBC TV 18 report.
He added that the vaccine candidates could adapt to any Covid-19 evolution and its possible mutations.
![comment](https://assetsbl.thehindubusinessline.com/theme/images/bl-online/1x1_spacer.png)
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.